Bio-Techne (TECH) is pleased to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers. Effective May 1, Bio-Techne will enter into a strategic distribution agreement with Thermo Fisher Scientific (TMO) in Europe. This partnership marks an important collaboration between two industry leaders in the fields of scientific research, diagnostics, and biotechnology. Under this agreement, Thermo Fisher, through the European arm of its Fisher Scientific Channel, will distribute Bio-Techne’s extensive portfolio of innovative products, including antibodies, proteins, Immunoassay kits, reagents and enzymes to laboratories and research institutions across Europe.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH:
- TECH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Bio-Techne and Novomol-Dx announces development of Bio-Marker Pathfinder
- Bio-Techne takes legal action in the Unified Patent Court in Europe
- Bio-Techne files patent infringement suit against Molecular Instruments
- Bio-Techne price target lowered to $82 from $85 at Deutsche Bank